ARCHIVES

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

Duke’s Victor Dzau Named President of The Institute of Medicine

February 21, 2014

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

NCAB Congress to Keep Cigarette Tax At 16 Cents

May 24, 1985

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

November 5, 2010

Cancer Letter Closes Out 1983, 10th Year

December 16, 1983

Subcommittee chairman Critical Of DCR For Lack Of “Game Plan”

October 28, 1977